Thursday, 1 March 2012

Food And Drug Administration-Treatment Of Breast Cancer-Healthday News

Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study

WEDNESDAY, Dec. 7 (HealthDay News) -- In November, the U.S. Food and Drug Administration revoked its approval of the drug Avastin for the treatment of breast cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications. read more..


Targeted Radiation May Not Be Better for Breast Cancer

WEDNESDAY, Dec. 7 (HealthDay News) -- Women with breast cancer who received radiation through strategically placed "seeds" had double the risk of a mastectomy later on, compared with women who got radiation for their entire breast, new research finds. read more..

No comments:

Post a Comment